BIOCQ — Biocept Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$4.46m
- $25.86m
U.S. STOCKS ON THE MOVE-Bluebird, World Wrestling Entertainment, Valero Energy
U.S. STOCKS ON THE MOVE-Biocept, Molson Coors, DCP Midstream
Biocept climbs on plan to cut jobs, explore options
Brief: Biocept Inc Estimates It Will Incur Charges Of About $0.6 Mln For Q1 2023 Severance Costs
Brief: Biocept To Explore Strategic Alternatives And Implement Restructuring Plan
Brief: Biocept Reports Third Quarter 2022 Financial Results
Brief: Biocept Appoints Financial Executive Quyen Dao-Haddock To Its Board Of Directors
Brief: Biocept Announces Participation In An Investigator-Initiated Study To Better Understand Development And Progression Of Metastatic Breast Cancer To Central Nervous System
Biocept Inc reports results for the quarter ended in June - Earnings Summary
Brief: Biocept Reports Second Quarter 2022 Financial Results
Biocept Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Biocept Expands Commercial Offering Of Cnside™ Assay To Most Cancers That Metastasize To The Central Nervous System
Biocept Inc expected to post a loss of 16 cents a share - Earnings Preview
Biocept Inc expected to post a loss of 16 cents a share - Earnings Preview
Biocept Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Plus Therapeutics, Biocept Announce Comprehensive Laboratory Services Deal For Respect-LM Trial
Biocept Inc reports results for the quarter ended in March - Earnings Summary
Brief: Biocept Reports First Quarter 2022 Financial Results
Brief: Biocept Announces Delay In Filing Of Its Quarterly Report On Form 10-Q